Clinical response of myelodysplastic syndromes patients to treatment with coenzyme Q10.

doi:10.1016/j.leukres.2006.04.009

Back to search

Article

Clinical response of myelodysplastic syndromes patients to treatment with coenzyme Q10.

Leukemia research - 1 Jan 2007

Galili Naomi, Sechman Eric V, Cerny Jan, Mehdi Murtaza, Mumtaz Muhammad, Westervelt Peter, Maguire Jessica, Raza Azra

Abstract excerpt

The myelodysplastic syndromes (MDS) are a collection of hematopoietic disorders with varying degrees of mono- to trilineage cytopenias and bone marrow dysplasia. In recent years much progress has been made in the treatment of MDS and there are now several therapeutic compounds used with varying l...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Leukocytes, Mononuclear

Share to Myelodysplastic Syndromes

Share to Thrombocytopenia

Share to Ubiquinone

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

Clinical response of myelodysplastic syndromes patients to treatment with coenzyme Q10.PMID 17064768Read

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.Semantic proximity Read

Myelodysplastic Syndromes: Updates and Nuances.Semantic proximity Read

Myelodysplastic Syndromes: A New Decade.Semantic proximity Read

Myelodysplastic SyndromesSemantic proximity Read

New strategies in myelodysplastic syndromes: application of molecular diagnostics to clinical practice.Semantic proximity Read

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.Semantic proximity Read

Myelodysplastic Syndrome Updated.Semantic proximity Read

Current therapeutic approaches for patients with myelodysplastic syndromes.Semantic proximity Read